WallStreetZenWallStreetZen

NASDAQ: NAUT
Nautilus Biotechnology Inc Stock

Open Broker Account
$1.82+0.01 (+0.55%)
Updated Dec 1, 2022
NAUT Price
$1.82
Fair Value Price
$3.34
Market Cap
$227.00M
52 Week Low
$1.71
52 Week High
$6.29
P/E
-3.71x
P/B
0.7x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$61.20M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.1
Operating Cash Flow
-$46M
Beta
1.25
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NAUT Overview

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NAUT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NAUT ($1.82) is undervalued by 45.44% relative to our estimate of its Fair Value price of $3.34 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
NAUT ($1.82) is significantly undervalued by 45.44% relative to our estimate of its Fair Value price of $3.34 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
NAUT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NAUT due diligence checks available for Premium users.

Be the first to know about important NAUT news, forecast changes, insider trades & much more!

NAUT News

Valuation

NAUT fair value

Fair Value of NAUT stock based on Discounted Cash Flow (DCF)
Price
$1.82
Fair Value
$3.34
Undervalued by
45.44%
NAUT ($1.82) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NAUT ($1.82) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NAUT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NAUT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.71x
Industry
14.11x
Market
22.16x

NAUT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.7x
Industry
4.98x
NAUT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NAUT's financial health

Profit margin

Revenue
$0.0
Net Income
-$14.1M
Profit Margin
0%
NAUT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$359.3M
Liabilities
$34.0M
Debt to equity
0.1
NAUT's short-term assets ($261.22M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NAUT's short-term assets ($261.22M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NAUT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$9.6M
Investing
-$11.9M
Financing
$86.0k
NAUT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NAUT vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
NAUT$227.00M-2.20%-3.71x0.70x
MOLN$230.20M-1.69%N/A0.91x
VYGR$233.19M+6.79%-13.42x2.92x
GRCL$233.48M-4.35%-2.81x0.98x
SPRY$233.66M+7.72%-2.68x0.87x

Nautilus Biotechnology Stock FAQ

What is Nautilus Biotechnology's quote symbol?

NASDAQ: NAUT) Nautilus Biotechnology trades on the NASDAQ under the ticker symbol NAUT. Nautilus Biotechnology stock quotes can also be displayed as NASDAQ: NAUT.

If you're new to stock investing, here's how to buy Nautilus Biotechnology stock.

What is the 52 week high and low for Nautilus Biotechnology (NASDAQ: NAUT)?

(NASDAQ: NAUT) Nautilus Biotechnology's 52-week high was $6.29, and its 52-week low was $1.71. It is currently -71.07% from its 52-week high and 6.43% from its 52-week low.

How much is Nautilus Biotechnology stock worth today?

(NASDAQ: NAUT) Nautilus Biotechnology currently has 124,723,525 outstanding shares. With Nautilus Biotechnology stock trading at $1.82 per share, the total value of Nautilus Biotechnology stock (market capitalization) is $227.00M.

Nautilus Biotechnology stock was originally listed at a price of $10.44 in Aug 7, 2020. If you had invested in Nautilus Biotechnology stock at $10.44, your return over the last 2 years would have been -82.57%, for an annualized return of -58.25% (not including any dividends or dividend reinvestments).

How much is Nautilus Biotechnology's stock price per share?

(NASDAQ: NAUT) Nautilus Biotechnology stock price per share is $1.82 today (as of Dec 1, 2022).

What is Nautilus Biotechnology's Market Cap?

(NASDAQ: NAUT) Nautilus Biotechnology's market cap is $227.00M, as of Dec 3, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nautilus Biotechnology's market cap is calculated by multiplying NAUT's current stock price of $1.82 by NAUT's total outstanding shares of 124,723,525.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.